S9 Ep72: Midweek Takeaway featuring Daniel Gee and James Sheehan from Priority Intelligence Group (AIM:PR1) #PR1
The Sunday Roast

S9 Ep72: Midweek Takeaway featuring Daniel Gee and James Sheehan from Priority Intelligence Group (AIM:PR1) #PR1

Mar 18, 2025
19:24
S9 · E72
-(0)

About this episode

In this episode of The Midweek Takeaway, we’re joined by Daniel Gee and James Sheehan from Pri0r1ty Intelligence Group PLC (AIM: PR1) to discuss their recent £100,000 contract with Leukaemia Care. The partnership will see Pri0r1ty develop an AI-powered information hub to enhance patient and donor communication, with a focus on accessibility, engagement, and fundraising support. We explore how the deal came about, its potential as a case study for future AI consultancy contracts, and the broader impact of AI in the charity and healthcare sectors. Could this be a blueprint for AI-driven support in patient care? Tune in to find out! Disclaimer & Declaration of Interest This podcast may contain paid promotions, including but not limited to sponsorships, endorsements, or affiliate partnerships. The information, investment views, and recommendations provided are for general informational purposes only and should not be construed as a solicitation to buy or sell any financial products related to the companies discussed. Any opinions or comments are made to the best of the knowledge and belief of the commentators; however, no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion. Listeners are encouraged to perform their own research and consult with a licensed professional before making any financial decisions based on the content of this podcast.

Comments

Rate this episode

Episode Details

Author
The Sunday Roast
Show Type
full
Audio Format
audio/mpeg

We use analytics

We use Umami, a privacy-friendly analytics tool, to understand how visitors use this site. No personal data is collected and no data leaves our EU servers. You can accept or decline below. Privacy Policy